Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 501 | 575 | 486 | 243 | 191 |
| Cost of Goods | 247 | 305 | 189 | 75 | 59 |
| Gross Profit | 254 | 271 | 298 | 168 | 133 |
| Operating Expenses | 1,798 | 1,619 | 1,597 | 1,616 | 1,593 |
| Operating Income | -1,297 | -1,043 | -1,111 | -1,373 | -1,401 |
| Interest Expense | 55 | 30 | 17 | 5 | 249 |
| Other Income | -5 | -2 | -1 | -6 | -55 |
| Pre-tax Income | -1,356 | -1,076 | -1,129 | -1,384 | -1,705 |
| Net Income Continuous | -1,356 | -1,076 | -1,129 | -1,384 | -1,705 |
| Net Income | $-1,356 | $-1,076 | $-1,129 | $-1,384 | $-1,705 |
| EPS Basic Total Ops | -0.20 | -0.16 | -0.16 | -0.20 | -0.30 |
| EPS Basic Continuous Ops | -0.19 | -0.16 | -0.16 | -0.20 | -0.30 |
| EPS Diluted Total Ops | -0.20 | -0.16 | -0.16 | -0.20 | -0.30 |
| EPS Diluted Continuous Ops | -0.19 | -0.16 | -0.16 | -0.20 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.15 | -0.16 | -0.20 | -0.29 |
| EBITDA(a) | $-1,278 | $-1,024 | $-1,099 | $-1,362 | $-1,388 |